FOR IMMEDIATE RELEASE
Director, Public Relations
BOSL & CO
BLVD FASHION HOUSE PRESENTS FASHION FOR A CURE
September 19, 2014 — BLVD Fashion House, the modeling arm of BOSL & CO., will be presenting 2 fashion shows at the Team Fox Second Life Autumn Gala tomorrow Saturday, September 20, 2014 at the Lefevre Mansion Ballroom. This special event sponsored by Lefevre and Hernandoz Foundation is a fund raiser for the Michael J Fox Foundation for Parkinson Research. The fashion shows will take place at 10:00AM and 5:00PM SLT and feature fashions from Artizana, Blue Moon Enterprise, Dot-Be Fashion, Image Factory, Sabra Style and Soul Designs.
There will be live music provided at 11:00AM SLT AM Quar, 3:00PM by Seth Regan and 4:00PM SLT by Erin Frog.
At 6:00PM SLT, there will be a live auction featuring unique designs from the fashion shows’ featured designers and proceeds from this auction along with sales from the various designer offerings will be donated to the charitable organization.
ABOUT BLVD FASHION HOUSE
BLVD Fashion House is one of the longest operating agencies in SL and features some of SL’s top fashion models. Being home to very special models with a discerning eye and a high level of professionalism is our acclaim. We are able to offer fashion shows that can take advantage of the immense coverage BOSL has as media to make very effective announcements for the shows, top class models and top class show productions for SL fashion designers and creators who are looking for first class fashion shows that enhance brand image. This agency is exclusive and models are welcome by invitation only. Applications are not accepted except for castings.
ABOUT LEFEVRE & HERNANDOZ FOUNDATION
The Lefevre & Hernandoz Foundation is the official group to coordinate benefit events and transactions for RGF Estates, Master S&M Estates, Fire Island Gay Beach and The Lefevre Mansion.
ABOUT MICHAEL J FOX FOUNDATION
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.